Poxviridae Infections Drug Market size was valued at USD value not foundin 2024 and is forecasted to grow at a CAGR of value not found% from 2026 to 2033, reaching USD value not found by 2033.
In 2022, the global market for drugs targeting Poxviridae infections, including monkeypox, was valued at approximately USD 200.23 million, with projections indicating growth to USD 184.79 million by 2030, reflecting a compound annual growth rate (CAGR) of 10.16% from 2022 to 2030. North America led the market, securing a revenue share exceeding 40.0%, driven by the presence of key industry players, heightened disease prevalence, and increased public awareness regarding vaccination. The regions market expansion is further supported by favorable governmental support and substantial investments in research and development. The Asia Pacific region is anticipated to experience the fastest growth during the forecast period, propelled by a rising number of monkeypox infections and intensified research and development efforts aimed at developing preventive and therapeutic solutions. Notably, countries such as Australia, Singapore, and India are witnessing an uptick in infection rates, which is expected to fuel market growth in this region. Additionally, the oral route of administration dominated the market in 2022, accounting for over 65.0% of the share, attributed to the higher demand for oral therapeutics, ease of administration, and cost effectiveness.
Get | Download Sample Copy with TOC, Graphs & List of Figures @ http://verifiedmarketreports.com/download-sample/?rid=484128&utm_source=Pulse_G_April&utm_medium=226
Bavarian Nordic A/S
BioFactura
CEL-SCI Corporation
Chimerix
China Biologic Products
CJ HealthCare Corp.
EpiVax
N & N Pharmaceuticals Inc.
SIGA Technologies
Takeda Pharmaceutical Company Limited
Tonix Pharmaceuticals Holding Corp.
Verrica Pharmaceuticals Inc.
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=484128&utm_source=Pulse_G_April&utm_medium=226
Growing demand for below applications around the world has had a direct impact on the growth of the Global Poxviridae Infections Drug Market
Freight Bogies
Passenger Bogies
Specialized Bogies
Urban Transport
Inter-City Transport
Freight Transport
Steel
Aluminum
Composite Materials
Conventional Technology
Advanced Technology
Smart Technology
Government and Municipalities
Private Sector
Railway Manufacturers
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ https://www.verifiedmarketreports.com/product/poxviridae-infections-drug-market-size-and-forecast/
1. Introduction of the Global Poxviridae Infections Drug Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Poxviridae Infections Drug Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Poxviridae Infections Drug Market, By Type
6. Global Poxviridae Infections Drug Market, By Application
7. Global Poxviridae Infections Drug Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Global Poxviridae Infections Drug Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/